Mathvink; Robert J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mathvink; Robert J..The latest application filed is for "3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes".

Company Profile

0.7.3

Mathvink; Robert J. - Red Bank NJ
Mathvink; Robert J. - Jersey City NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,388,019 - Ashton , et al. June 17, 2	2008-06-17
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,309,714 - Duffy , et al. December 18, 2	2007-12-18
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,265,128 - Ashton , et al. September 4, 2	2007-09-04
Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes Grant 7,208,498 - Mathvink , et al. April 24, 2	2007-04-24
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,157,490 - Colandrea , et al. January 2, 2	2007-01-02
3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20060074087 - Ashton; WallaceT ; et al.	2006-04-06
Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes App 20060040963 - Mathvink; Robert J. ; et al.	2006-02-23
Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20050222140 - Colandrea, Vincent J. ; et al.	2005-10-06
Thiazole benzenesulfonamides as .beta.3 agonists for treatment of diabetes and obesity Grant 6,011,048 - Mathvink , et al. January 4, 2	2000-01-04
Substituted phenyl sulfonamides as selective .beta. 3 agonists for the treatment of diabetes and obesity Grant 5,451,677 - Fisher , et al. September 19, 1	1995-09-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.